Neuron News and Research

RSS

Hearing-protection tablet helps soldiers defend against hearing loss

Soldiers exposed to the deafening din of battle have little defense against hearing loss, and are often reluctant to wear protective gear like ear plugs that could make them less able to react to danger.

31 Mar 2007

Molecular mechanism involved in development of schizophrenia

In studying the postmortem brain tissue of adults who had been diagnosed with schizophrenia, the researchers found that levels of certain gene-regulating molecules called microRNAs were lower among schizophrenia patients than in persons who were free of psychiatric illness.

30 Mar 2007

Glimpse into early brain development shows how nerve cells move into position

Tucked into the lower, rear portion of the brain, the cerebellum plays key roles in motor learning, motor memory and sensory perception. It's also where the majority of metastatic childhood brain tumors are located. Yet scientists still know very little about its early growth.

29 Mar 2007

Atorvastatin shows potential as a new treatment for spinal cord injuries

A multidisciplinary investigation led by Inderjit Singh, Ph.D, of the Medical University of South Carolina, has resulted in a new treatment of spinal cord injuries (SCI). The study investigates the efficacy of atorvastatin (AT), (i.e. Lipitor) as a treatment for spinal cord injuries following trauma.

22 Mar 2007

Curry related compound shows promise against Kennedy's disease

Scientists who focus on the molecular signaling that underlies prostate cancer have discovered a compound that shows promise against a debilitating neurodegenerative condition known as Kennedy's disease, which is caused by a mutant gene.

21 Mar 2007

Chemical cues turn embryonic stem cells into cerebellar neurons

Embryonic stem cells have shown a great deal of promise for alleviating heart disease and regenerating organs. But for some of the conditions for which people hold out the most hope - Alzheimer's and Parkinson's, for example - there's been little evidence to date that stem cells can work.

14 Mar 2007

Stem cells delay neurodegeneration in the brain

Sufferers from devastating neurodegenerative diseases have been given some hope by the results of recent research.

12 Mar 2007

Gene tests and brain imaging reveal early dementia

Dementia diseases develop insidiously and are generally discovered when the memory has already started to deteriorate. New research form Karolinska Institutet shows, however, that approaching Alzheimer's can be detected several years before the symptoms manifest themselves.

6 Mar 2007

Rare cell prevents rampant brain activity

One of the mysteries of the brain is how it avoids ending up in a state of chaos, something which happens only on exceptional occasions, when it can lead to epileptic fits.

4 Mar 2007

New insight into brain disorders

The function of an enzyme in the brain - strongly linked to a number of major brain diseases such as Alzheimer's, schizophrenia and bi-polar disorder - has been identified for the first time by researchers at the University of Bristol.

1 Mar 2007

microRNAs undergo molecular editing with significant physiological consequences

Tiny molecules called microRNAs, only 19 to 21 nucleotides in length, are able to effectively silence sometimes large sets of genes. They do this by specifically binding to and neutralizing another form of RNA called messenger RNA, responsible for conveying the information from genes to the cellular machinery that uses that information to create proteins, the building blocks of the body.

22 Feb 2007

Smoking produces biochemical changes in human brain

New research shows for the first time that smoking produces long-lasting biochemical changes in the human brain similar to those changes previously seen in the brains of animals that used cocaine, heroin, and other illicit drugs.

20 Feb 2007

Results of largest ever genome study of autism released

The genomes of the largest collection of families with multiple cases of autism ever assembled have been scanned and the preliminary results published in Nature Genetics. They provide new insights into the genetic basis of autism.

From The University of Manchester 19 Feb 2007

Genetic variations contribute to a person's risk for nicotine dependence

Americans are bombarded with antismoking messages, yet at least 65 million of us continue to light up. Genetic factors play an important role in this continuing addiction to cigarettes, suggest scientists at Washington University School of Medicine in St. Louis.

18 Feb 2007

Largest collection of autism DNA

Preliminary findings from the largest genome scan ever completed in the history of autism research are being published in Nature Genetics. University of Pittsburgh researchers with a consortium of scientists from across the world contributed to this landmark research endeavor through the Autism Genome Project.

18 Feb 2007

Back regions of the brain, which control vision, grow significantly faster than prefrontal region in newborns

The regions of the brain that control vision and other sensory information grow dramatically in the first few months following birth, while the area that controls abstract thought experiences very little growth during the same period, University of North Carolina at Chapel Hill researchers have found.

11 Feb 2007

UK scientists reverse symptoms of mad cow disease

The researchers at University College, London, believe they have found a way to treat the disease in humans as long as it is detected before it has done harm to a large number of brain cells.

1 Feb 2007

Effects of prion disease could be reversed if caught early enough

The researchers said that their findings support developing early treatments that aim to reduce levels of prion protein in the brains of people with prion disease.

31 Jan 2007

Calpain-mediated mGluR1-alpha truncation

Tricking a key enzyme can soothe over-excited receptors in the brain, say neuroscientists, calling this a possible strategy against stroke, Alzheimer's and other neurodegenerative diseases.

31 Jan 2007

FDA approves Neuren's phase 3 Glypromate trial

Neuren Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has accepted its investigational new drug application (IND) and authorised the Company to proceed with its Phase 3 trial to prevent cognitive impairment following major cardiac surgery using Glypromate.

30 Jan 2007